Premium
Plasma prolactin and breast cancer
Author(s) -
Wilson R. G.,
Buchan R.,
Roberts M. M.,
Forrest A. P. M.,
Boyns A. R.,
Cole E. N.,
Griffiths K.
Publication year - 1974
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197405)33:5<1325::aid-cncr2820330517>3.0.co;2-v
Subject(s) - medicine , prolactin , radioimmunoassay , breast cancer , stilbestrol , cancer , oncology , endocrinology , disease , gynecology , estrogen , diethylstilbestrol , hormone
Using a homologous radioimmunoassay we have compared plasma prolactin concentrations in 49 patients with breast cancer and 39 hospital controls. When a drug history was taken into account no difference was found. In addition we have studied the effect of Stilbestrol in 6 females with advanced breast cancer. Remission of disease has been noted in the face of elevated prolactin levels.